Skip to main content

Advertisement

Log in

Squamous Cell Carcinoma Antigen in Lung Cancer and Nonmalignant Respiratory Diseases

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Study Objectives Squamous cell carcinoma antigen (SCC) has been found in elevated amounts in patients with squamous cell lung cancer (SQLC). Elevated levels have also been found among patients with nonsquamous cell lung cancer (NSQLC) and in subjects with nonmalignant pulmonary disease (NMPD). The purpose of the current study was to evaluate SCC levels among a large number of patients with SQLC, NSQLC, and NMPD. Six hundred thirty-nine lung cancer patients, including 201 SQLC patients and 299 patients with NMPD, who were diagnosed at our hospital up to 2006 were entered. Serum SCC levels were measured with a commercially available kit. Results Elevated levels (>1.5 ng/ml) of SCC were observed in 52.7% of SQLC patients, but in only 14.2% of NSQLC patients. There was a statistically significant difference in positive rate between SQLC and NSQLC patients. None of the NSQLC patients had serum SCC levels greater than 40.0 ng/ml. Among subjects with NMPD, 28.4% had elevated levels of SCC. However, none of the NMPD patients had serum SCC levels greater than 20.0 ng/ml. Conclusions Serum levels of SCC can be elevated (<20.0 ng/ml) in some NMPD patients without coexisting SQLC. Patients with NSQLC and NMPD with elevated SCC levels greater than 40 ng/ml may have coexisting SQLC or squamous cell carcinoma in an extrapulmonary site.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kato H, Torigoe T (1977) Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40:1621–1628

    Article  PubMed  CAS  Google Scholar 

  2. Torre GC (1998) SCC antigen in malignant and nonmalignant squamous lesions. Tumour Biol 19:517–526

    Article  PubMed  CAS  Google Scholar 

  3. Takeda M, Sakuragi N, Okamoto K, Todo Y, Minobe S, Nomura E, Negishi H, Oikawa M, Yamamoto R, Fujimoto S (2002) Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix. Acta Obstet Gynecol Scand 81:451–457

    Article  PubMed  Google Scholar 

  4. Ando S, Kimura H, Iwai N, Kakizawa K, Shima M, Ando M (2003) The significance of tumour markers as an indication for mediastinoscopy in non-small cell lung cancer. Respirology 8:163–167

    Article  PubMed  Google Scholar 

  5. Kato H, Ogata H (1999) Squamous cell carcinoma antigen. Nippon Rinsho 57:510–512 (in Japanese)

    Google Scholar 

  6. Sánchez De Cos J, Masa F, de la Cruz JL, Disdier C, Vergara C (1994) Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer. Chest 105:773–776

    Article  PubMed  Google Scholar 

  7. Moro D, Villemain D, Vuillez JP, Delord CA, Brambilla C (1995) CEA, CYFRA21-1 and SCC in non-small cell lung cancer. Lung Cancer 13:169–176

    Article  PubMed  CAS  Google Scholar 

  8. Takeuchi S, Nonaka M, Kadokura M, Takaba T (2003) Prognostic significance of serum squamous cell carcinoma antigen in surgically treated lung cancer. Ann Thorac Cardiovasc Surg 9:98–104

    PubMed  Google Scholar 

  9. Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S (2008) Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Lung Cancer 58:369–375

    Article  Google Scholar 

  10. Sarandakou A, Protonotariou E, Rizos D (2007) Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci 44:151–178

    Article  PubMed  CAS  Google Scholar 

  11. Tramonti G, Ferdeghini M, Donadio C, Norpoth M, Annichiarico C, Bianchi R, Bianchi C (2000) Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia. Cancer Detect Prev 24:86–90

    PubMed  CAS  Google Scholar 

  12. Kashiwabara K, Nakamura H, Yagyu H, Kishi K, Matsuoka T, Esaki T (2000) Changes in squamous cell carcinoma-related antigen levels before and after hemodialysis in relation to the model of dialyzer employed. Intern Med 39:291–295

    Article  PubMed  CAS  Google Scholar 

  13. Kudo H, Yamamoto M, Miyachi Y, Danno K, Imamura S (1988) Increased serum levels of squamous cell carcinoma-related antigen in pemphigus. Br J Dermatol 118:471–474

    Article  PubMed  CAS  Google Scholar 

  14. Tsukahara T, Otoyama K, Horiuchi Y (1993) Significance of elevated serum squamous cell carcinoma (SCC)-related antigen and lactate dehydrogenase (LDH) levels in senile erythroderma following eczema. J Dermatol 20:346–350

    PubMed  CAS  Google Scholar 

  15. Ferrer J, Villarino MA, Encabo G, Felip E, Bermejo B, Vilà S, Orriols R (1999) Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 86:1488–1495

    Article  PubMed  CAS  Google Scholar 

  16. Lai RS, Hsu HK, Lu JY, Ger LP, Lai N (1996) CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer. Chest 109:995–1000

    CAS  Google Scholar 

  17. Ashitani J, Mukae H, Ihiboshi H, Taniguchi H, Mashimoto H, Matsukura S (1996) Adult respiratory distress syndrome with increased serum and bronchoalveolar lavage fluid levels of squamous cell carcinoma-related antigen. Intern Med 35:497–501

    Article  PubMed  CAS  Google Scholar 

  18. Sakito O, Kadota J, Kohno S, Itoh N, Takahara O, Hara K (1994) Pulmonary infiltration with eosinophilia and increased serum levels of squamous cell carcinoma-related antigen and neuron specific enolase. Intern Med 33:550–553

    Article  PubMed  CAS  Google Scholar 

  19. Bando M, Tani K, Kohrai F, Sano T, Kitamura S (1994) A case of sarcoidosis with elevated SCC antigen in the serum and broncho-alveolar lavage fluid which was difficult to distinguish from lung cancer. Nihon Kyobu Shikkan Gakkai Zasshi 32:95–100 (in Japanese)

    Google Scholar 

  20. Molina R, Filella X, Torres MD, Ballesta AM, Mengual P, Cases A, Balaque A (1990) SCC antigen measured in malignant and nonmalignant diseases. Clin Chem 36:251–254

    PubMed  CAS  Google Scholar 

  21. Cheah PL, Liam CK, Yap SF, Looi LM (1994) Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung. J Clin Pathol 47:535–537

    Article  PubMed  CAS  Google Scholar 

  22. Ueda G, Inoue Y, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Saito J, Nishino T, Abe Y (1984) Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors. Int J Gynecol Pathol 3:291–298

    Article  PubMed  CAS  Google Scholar 

  23. Mino-Miyagawa N, Kimura Y, Hamamoto K (1990) Tumor-antigen 4. Its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus. Cancer 66:1505–1512

    CAS  Google Scholar 

  24. World Health Organization (1999) Histological typing of lung and pleural tumours. International histological classification of tumours, 3rd edn. WHO, Geneva

    Google Scholar 

  25. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717

    Article  PubMed  CAS  Google Scholar 

  26. Ferrigno D, Buccheri G (1995) Clinical applications of serum markers for lung cancer. Respir Med 89:587–597

    Article  PubMed  CAS  Google Scholar 

  27. Body JJ, Sculier JP, Raymakers N, Paesmans M, Ravez P, Libert P, Richez M, Dabouis G, Lacroix H, Bureau G et al (1990) Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer. Cancer 65:1552–1556

    Article  PubMed  CAS  Google Scholar 

  28. Kodama T, Satoh H, Ishikawa H, Ohtsuka M (2007) Serum levels of CA19-9 in patients with nonmalignant respiratory diseases. J Clin Lab Anal 21:103–106

    Article  PubMed  CAS  Google Scholar 

  29. Nakayama M, Satoh H, Ishikawa H, Fujiwara M, Kamma H, Ohtsuka M, Sekizawa K (2003) Cytokeratin 19 fragment in patients with nonmalignant respiratory diseases. Chest 123:2001–2006

    Article  PubMed  CAS  Google Scholar 

  30. Satoh H, Kamma H, Ogata T, Ohtsuka O, Hasegawa S (1991) Clinical significance of serum levels of a carbohydrate antigen, sialyl SSEA-1, in patients with fibrosing lung disease. Am Rev Respir Dis 144:1177–1181

    PubMed  CAS  Google Scholar 

  31. Kagohashi K, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K (2008) A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small-cell lung cancer. Med Oncol 25:187–189

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroaki Satoh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kagohashi, K., Satoh, H., Kurishima, K. et al. Squamous Cell Carcinoma Antigen in Lung Cancer and Nonmalignant Respiratory Diseases. Lung 186, 323–326 (2008). https://doi.org/10.1007/s00408-008-9108-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-008-9108-4

Keywords

Navigation